Diabetic eye screening that happens in the Primary Care setting
Our overall goal is to increase access to high-quality specialized healthcare at scale. We are doing so by building AI systems such as the RETINA-AI Galaxy™ that move specialized healthcare services into primary care settings. Examples of primary care settings include family doctor offices, retail clinics, and pharmacies.
The Galaxy web app is a Software as a Medical Device (SaMD) and it's our flagship product. We are increasing healthcare access globally by building cutting-edge AI Technology that improves both quality and affordability of highly specialized care.
We are an eye-centric healthtech company with a pipeline of products in our roadmap. In addition to diabetic retinopathy, other conditions which AI can be used to detect in the retina include glaucoma, macular degeneration, cardiovascular risk, and dementia.
Our team is made up of healthcare, AI/ML and software industry experts from
Dr. Stephen G. Odaibo
Founder, CEO, and Chief Data Engineer
Dr. Stephen G. Odaibo is a Retina specialist, Mathematician, Computer Scientist, and Full-Stack AI Engineer. He is the first Ophthalmologist in the world to ever hold advanced degrees in both Mathematics and Computer Science. In 2017 UAB College of Arts & Sciences awarded Dr. Odaibo its highest honor: The Distinguished Alumni Achievement Award. In 2005 he won the Barrie Hurwitz Award for Excellence in Clinical Neurology at Duke Univ. School of Medicine where he topped the class in Neurology and in Pediatrics. In 2021 Dr. Odaibo was awarded a U.S. Patent for inventing an AI system to automatically diagnose eye diseases from images. He is author of the book “Quantum Mechanics and the MRI Machine'' (2012), and of the book "The Form of Finite Groups: A Course on Finite Group Theory" (2016).